Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282 |
filingDate |
2012-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-101647569-B1 |
titleOfInvention |
Combination therapy for ovarian cancer |
abstract |
The present invention relates to a pharmaceutical composition comprising gemcitabine, cisplatin or carboplatin and 5- [2-tert-butyl-5- (4-fluoro-phenyl) Dimethyl-propyl) -3H-imidazo [4,5-b] pyridin-2-ylamine in a mammal in need of such treatment. . |
priorityDate |
2011-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |